New research using APP-KI mice reveals that reduced dopamine signaling contributes significantly to memory decline in Alzheimer's disease, highlighting a previously underrecognized pathway alongside amyloid-β accumulation. Young APP-KI mice aged 3-6 months showed 78.6% correct trials for new odor associations versus 90.6% in wild-type mice, with performance declining further in older mice to 67.9% versus 84.9%. The study found that lateral entorhinal cortex layer 2/3 neurons, controlled by dopamine inputs from the ventral tegmental area and substantia nigra pars compacta, are critical for forming new associative memories but not retrieving existing ones. Researchers recorded 846 neurons from young APP-KI mice showing altered firing patterns and increased cue responses compared to wild-type controls. The findings align with fMRI studies showing the lateral entorhinal cortex suffers the earliest activity loss in Alzheimer's patients, potentially offering new therapeutic targets beyond current amyloid-focused treatments.
Story comments
Loading comments…